Article
Lymphangiogenic Gene Therapy With Minimal Blood Vascular Side Effects
16 Sept 2002
Abstract excerpt
Recent work from many laboratories has demonstrated that the vascular endothelial growth factor-C/VEGF-D/VEGFR-3 signaling pathway is crucial for lymphangiogenesis, and that mutations of the Vegfr3 gene are associated with hereditary lymphedema. Furthermore, VEGF-C gene transfer to the skin of mice with lymphedema induced a regeneration of the cutaneous lymphatic vessel network. However, as is the case with VEGF,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.